Short Interest in Advanced Biomed Inc. (NASDAQ:ADVB) Decreases By 72.7%

Advanced Biomed Inc. (NASDAQ:ADVB) was the recipient of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totaling 13,424 shares, a decrease of 72.7% from the April 15th total of 49,188 shares. Based on an average daily trading volume, of 44,188 shares, the short-interest ratio is presently 0.3 days. Approximately 1.5% of the company’s stock are short sold.

Advanced Biomed Trading Up 4.5%

Shares of ADVB traded up $0.20 during mid-day trading on Friday, reaching $4.63. The company’s stock had a trading volume of 4,819 shares, compared to its average volume of 391,062. Advanced Biomed has a 12-month low of $3.61 and a 12-month high of $25.60. The firm has a market capitalization of $6.29 million, a PE ratio of 1.22 and a beta of 0.56. The firm’s 50 day moving average price is $5.20.

Analysts Set New Price Targets

Separately, Weiss Ratings initiated coverage on shares of Advanced Biomed in a report on Monday, January 26th. They set a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.